{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:35:59Z","timestamp":1768883759171,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["LA1177\/12-1"],"award-info":[{"award-number":["LA1177\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008751","name":"German Federal Institute for Risk Assessment","doi-asserted-by":"publisher","award":["1322-591"],"award-info":[{"award-number":["1322-591"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008751","name":"German Federal Institute for Risk Assessment","doi-asserted-by":"publisher","award":["1322-624"],"award-info":[{"award-number":["1322-624"]}],"id":[{"id":"10.13039\/501100008751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.cbi.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T11:46:08Z","timestamp":1542627968000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells"],"prefix":"10.1016","volume":"298","author":[{"given":"Johanna","family":"Ebmeyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Behrend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5267-4101","authenticated-orcid":false,"given":"Mario","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Reif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan G.","family":"Hengstler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Braeuning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Lampen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hessel-Pras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.11.007_bib1","first-page":"83","article-title":"Medicinal plants in Europe containing pyrrolizidine alkaloids","volume":"50","author":"Roeder","year":"1995","journal-title":"Pharmazie"},{"key":"10.1016\/j.cbi.2018.11.007_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/np50014a001","article-title":"Plant sources of hepatotoxic pyrrolizidine alkaloids","volume":"44","author":"Smith","year":"1981","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.cbi.2018.11.007_bib3","first-page":"95","article-title":"Pyrrolizidine alkaloid plants, metabolism and toxicity","volume":"8","author":"Stegelmeier","year":"1999","journal-title":"J.\u00a0Nat. Toxins"},{"key":"10.1016\/j.cbi.2018.11.007_bib4","series-title":"Pyrrolizidine Alkaloids - Structure and Toxicity","author":"Wiedenfeld","year":"2008"},{"key":"10.1016\/j.cbi.2018.11.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DMR-120028426","article-title":"Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms","volume":"36","author":"Fu","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2018.11.007_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/jat.1504","article-title":"Genotoxicity of pyrrolizidine alkaloids","volume":"30","author":"Chen","year":"2010","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib7","article-title":"Scientific opinion on pyrrolizidine alkaloids in food and feed - EFSA Panel on Contaminants in the Food Chain (CONTAM)","volume":"9","year":"2011","journal-title":"EFSA J."},{"key":"10.1016\/j.cbi.2018.11.007_bib8","series-title":"Chemistry and Toxicology of Pyrrolizidine Alkaloids","first-page":"316","author":"Mattocks","year":"1986"},{"key":"10.1016\/j.cbi.2018.11.007_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/19440049.2010.541288","article-title":"Plants containing pyrrolizidine alkaloids: toxicity and problems","volume":"28","author":"Wiedenfeld","year":"2011","journal-title":"Food Addit. Contam. A"},{"key":"10.1016\/j.cbi.2018.11.007_bib10","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/tx500071q","article-title":"Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis","volume":"27","author":"Ruan","year":"2014","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib11","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2460\/ajvr.1991.52.01.146","article-title":"Toxicity of pyrrolizidine alkaloids from Riddell groundsel (Senecio riddellii) to cattle","volume":"52","author":"Molyneux","year":"1991","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.cbi.2018.11.007_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","article-title":"Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids","volume":"39","author":"Chojkier","year":"2003","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.cbi.2018.11.007_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cbi.2018.11.007_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2036.2006.02742.x","article-title":"Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome","volume":"23","author":"Helmy","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2018.11.007_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0887-2333(95)00033-5","article-title":"Endothelial cells in culture: a model to study in\u00a0vitro vascular toxicity","volume":"9","author":"Chappey","year":"1995","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2018.11.007_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1152\/ajpgi.00526.2002","article-title":"Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome","volume":"284","author":"DeLeve","year":"2003","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.cbi.2018.11.007_bib17","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/hep.1840190515","article-title":"Venoocclusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms","volume":"19","author":"Shulman","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2018.11.007_bib18","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/jat.3470","article-title":"The use of human umbilical vein endothelial cells (HUVECs) as an in\u00a0vitro model to assess the toxicity of nanoparticles to endothelium: a review","volume":"37","author":"Cao","year":"2017","journal-title":"J.\u00a0Appl. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib19","first-page":"347","article-title":"Methods for detecting carcinogens and mutagens with the salmonella\/mammalian-microsome mutagenicity test","volume":"31","author":"Ames","year":"1975","journal-title":"Mutat. Res.-Envir. Muta."},{"key":"10.1016\/j.cbi.2018.11.007_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A\u00a0rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2018.11.007_bib21","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.cbi.2018.11.007_bib22","series-title":"Pyrrolizidine Alkaloids in Herbal Teas and Teas, BfR Opinion No 018\/2013 of 5 July 2013","author":"BfR","year":"2013"},{"key":"10.1016\/j.cbi.2018.11.007_bib23","article-title":"Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements - EFSA panel on contaminants in the food chain (CONTAM)","volume":"15","author":"EFSA","year":"2017","journal-title":"EFSA J."},{"key":"10.1016\/j.cbi.2018.11.007_bib24","article-title":"Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic","volume":"282","author":"EFSA","year":"2005","journal-title":"EFSA J."},{"key":"10.1016\/j.cbi.2018.11.007_bib25","series-title":"Pyrrolizidine Alkaloids: Levels in Foods Should Continue to Be Kept as Low as Possible, BfR Opinion No 030\/2016 of 28 September 2016","author":"BfR","year":"2016"},{"key":"10.1016\/j.cbi.2018.11.007_bib26","series-title":"Updated Risk Evaluation of Levels of 1,2-unsaturated Pyrrolizidine Alkaloids (PA) in Foods, BfR Opinion No 020\/2018 of 14 June 2018","author":"BfR","year":"2018"},{"key":"10.1016\/j.cbi.2018.11.007_bib27","author":"Warentest"},{"key":"10.1016\/j.cbi.2018.11.007_bib28","first-page":"352","article-title":"Mutagenicity of the pyrrolizidine (Senecio) alkaloid, lasiocarpine in the salmonella\/microsome test","volume":"38","author":"Koletsky","year":"1978","journal-title":"Lab. Invest."},{"key":"10.1016\/j.cbi.2018.11.007_bib29","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.tiv.2015.06.021","article-title":"Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: a whole genome transcriptome analysis","volume":"29","author":"Luckert","year":"2015","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2018.11.007_bib30","series-title":"Technical Report on the Toxicology and Carcinogenesis Studies of Riddelliine in F344\/N Rats and B6C3F1 Mice","author":"National Institutes of Health","year":"2003"},{"key":"10.1016\/j.cbi.2018.11.007_bib31","first-page":"825","article-title":"Hepatotoxicity of pyrrolizidine alkaloids","volume":"18","author":"Neuman","year":"2015","journal-title":"J.\u00a0Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2018.11.007_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.fct.2018.02.036","article-title":"Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: single versus repeated exposure","volume":"114","author":"Waizenegger","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0165-1218(79)90152-6","article-title":"Mutagenicity of pyrrolizidine alkaloids in the salmonella\/mammalian-microsome test","volume":"68","author":"Yamanaka","year":"1979","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2018.11.007_bib34","series-title":"Toxicants of Plant Origin","article-title":"Human health implications of pyrrolizidine alkaloids and herbs containing them","author":"Huxtable","year":"1989"},{"key":"10.1016\/j.cbi.2018.11.007_bib35","first-page":"2010","article-title":"An outbreak of hepatic veno-occlusive disease in Western Afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids","author":"Kakar","year":"2010","journal-title":"J.\u00a0Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(76)90727-3","article-title":"An epidemic of veno-occlusive disease of liver in central India","volume":"308","author":"Tandon","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2018.11.007_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3109\/00498254.2012.679978","article-title":"Comparison of metabolism-mediated effects of pyrrolizidine alkaloids in a HepG2\/C3A cell-S9 co-incubation system and quantification of their glutathione conjugates","volume":"42","author":"Tamta","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2018.11.007_bib38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-7992(92)90091-U","article-title":"The clastogenic potential in vitro of pyrrolizidine alkaloids employing hepatocyte metabolism","volume":"282","author":"M\u00fcller","year":"1992","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2018.11.007_bib39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.67.6.1174","article-title":"Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease","volume":"67","author":"FitzGerald","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2018.11.007_bib40","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscl. Throm. Vas."},{"key":"10.1016\/j.cbi.2018.11.007_bib41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2174\/1874192401004010302","article-title":"The endothelium and its role in regulating vascular tone","volume":"4","author":"Sandoo","year":"2010","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.cbi.2018.11.007_bib42","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2018.11.007_bib43","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cbi.2018.11.007_bib44","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3748\/wjg.v16.i12.1430","article-title":"COX-2 in liver, from regeneration to hepatocarcinogenesis: what we have learned from animal models?","volume":"16","author":"Mart\u00edn-Sanz","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cbi.2018.11.007_bib45","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.4049\/jimmunol.167.5.2831","article-title":"Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-21","volume":"167","author":"Caughey","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.cbi.2018.11.007_bib46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/oxfordjournals.bmb.a071832","article-title":"The prostacyclin-thromboxane A2 balance: pathophysiological and therapeutic implications","volume":"39","author":"Bunting","year":"1983","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.cbi.2018.11.007_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.007_bib48","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.ATV.2.3.193","article-title":"Prostacyclin and arterial wall biology","volume":"2","author":"Moncada","year":"1982","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.cbi.2018.11.007_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3181\/00379727-176-41847","article-title":"Monocrotaline-induced pulmonary endothelial dysfunction in rats","volume":"176","author":"Molteni","year":"1984","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.cbi.2018.11.007_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/096032719801701007","article-title":"Prostanoid production in endothelial and Kupffer liver cells from monocrotaline intoxicated rats","volume":"17","author":"Lemberg","year":"1998","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cbi.2018.11.007_bib51","first-page":"707","article-title":"The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells","volume":"138","author":"Reindel","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cbi.2018.11.007_bib52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"McAdam","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Suppl","key":"10.1016\/j.cbi.2018.11.007_bib53","doi-asserted-by":"crossref","first-page":"S423","DOI":"10.1194\/jlr.R800094-JLR200","article-title":"Prostanoids in health and disease","volume":"50","author":"Smyth","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.cbi.2018.11.007_bib54","series-title":"Textbook of Veterinary Physiological Chemistry","first-page":"434","article-title":"Chapter 68 - eicosanoids I","author":"Engelking","year":"2015"},{"key":"10.1016\/j.cbi.2018.11.007_bib55","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jcp.2003.012120","article-title":"Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis","volume":"57","author":"Mohammed","year":"2004","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.cbi.2018.11.007_bib56","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2018.11.007_bib57","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00005344-199601000-00004","article-title":"Protective effect of beraprost sodium, a stable prostacyclin analogue, in development of monocrotaline-induced pulmonary hypertension","volume":"27","author":"Miyata","year":"1996","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cbi.2018.11.007_bib58","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1253\/circj.CJ-13-0738","article-title":"Novel oral prostacyclin analog with thromboxane synthase inhibitory activity for management of pulmonary arterial hypertension","volume":"77","author":"Tran","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.cbi.2018.11.007_bib59","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2165\/00063030-199708060-00002","article-title":"Interleukin-11","volume":"8","author":"Dorner","year":"1997","journal-title":"BioDrugs"},{"key":"10.1016\/j.cbi.2018.11.007_bib60","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/sj.leu.2401514","article-title":"Hematopoietic, immunomodulatory and epithelial effects of interleukin-11","volume":"13","author":"Schwertschlag","year":"1999","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2018.11.007_bib61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/stem.5530140720","article-title":"Cytokine-induced alteration of platelet and hemostatic function","volume":"14","author":"Burstein","year":"1996","journal-title":"Stem Cell."},{"key":"10.1016\/j.cbi.2018.11.007_bib62","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0005-2760(91)90032-D","article-title":"Prostaglandin endoperoxide synthase: regulation of enzyme expression","volume":"1083","author":"DeWitt","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2018.11.007_bib63","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0006-291X(88)80944-6","article-title":"Additive effects of il-1 and tnf on induction of prostacyclin synthesis in human vascular endothelial cells","volume":"156","author":"Endo","year":"1988","journal-title":"Biochem. Biophys. Res. Co."},{"key":"10.1016\/j.cbi.2018.11.007_bib64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1600-0609.1997.tb00985.x","article-title":"Serum levels of cytokines after bone marrow transplantation: increased IL-8 levels during severe veno-occlusive disease of the liver","volume":"59","author":"Remberger","year":"1997","journal-title":"Eur. J. Haematol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718310779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718310779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:51:24Z","timestamp":1757857884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718310779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":64,"alternative-id":["S0009279718310779"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.11.007","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrrolizidine alkaloid-induced alterations of prostanoid synthesis in human endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}